Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04160312 · ClinicalTrials.gov registry record · NA
Mitopure™ (Proprietary Urolithin A) Bioavailability in Healthy Adults
A NA study, sponsored by Amazentis.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT04160312: Completed NA study, sponsored by Amazentis.
NCT04160312 is a NA study that has completed, run by Amazentis. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04160312, a NA study, has completed, sponsored by Amazentis.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This is a single-center, two-period, crossover, randomized, open labelled study enrolling 100 healthy subjects to evaluate the Urolithin A producer status and to compare bioavailabilty of direct dietary supplementation with Mitopure™ (proprietary Urolithin A) to dietary exposure with pomegranate juice
Interventions
- DIETARY_SUPPLEMENT Pomegranate Juice
- DIETARY_SUPPLEMENT Mitopure™ (Proprietary Urolithin A)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-11-08 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
What the finished NCT04160312 record still lists
NCT04160312 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Pomegranate Juice is the first listed.
NCT04160312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04160312 about?
NCT04160312 is a clinical study titled "Mitopure™ (Proprietary Urolithin A) Bioavailability in Healthy Adults". This is a single-center, two-period, crossover, randomized, open labelled study enrolling 100 healthy subjects to evaluate the Urolithin A producer status and to compare bioavailabilty of direct dietary supplementation with Mitopure™ (proprietary Urolithin A) to dietary exposure with pomegranate jui...
What is the current status of trial NCT04160312?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2019-11-08. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT04160312?
The interventions under investigation include: Pomegranate Juice (DIETARY_SUPPLEMENT), Mitopure™ (Proprietary Urolithin A) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04160312?
This trial is sponsored by Amazentis, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04160312's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI